The average one-year price target for Jade Biosciences (NasdaqCM:JBIO) has been revised to $19.38 / share. This is an increase of 13.43% from the prior estimate of $17.08 dated September 27, 2025. The ...
Every investor in Jade Biosciences, Inc. (NASDAQ:JBIO) should be aware of the most powerful shareholder groups. With 26% stake, institutions possess the maximum shares in the company. That is, the ...
The latest price target for Jade Biosciences (NASDAQ:JBIO) was reported by Clear Street on November 25, 2025. The analyst firm set a price target for $25.00 expecting JBIO to rise to within 12 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback